Tylenol class action lawsuit (2023)
3
Connections
1
Sources
1
Quality /10
2
Entity Types
A class action lawsuit filed against Johnson & Johnson/Kenvue by parents and guardians of children with autism and ADHD alleging Tylenol's links to neurodevelopmental disorders; dismissed by Judge Denise Cote for unreliable expert testimony.
Connection Graph
Top 3 connections · Full graph →
Key Relationships
Testified In
- Person Denise Cote - Federal Judge Denise Cote presided over the class action lawsuit against Johnson & Johnson/Kenvue and dismissed it, f... Credible Reporting
Mentioned In
- Organization Johnson & Johnson - Johnson & Johnson was named as a defendant in the class action lawsuit regarding Tylenol and alleged links to autism ... Credible Reporting
- Organization Kenvue - Kenvue, as the maker of Tylenol, was sued along with Johnson & Johnson in the class action lawsuit alleging deceptive... Credible Reporting
Source Documents & Evidence
“In 2023, Andrea Baccarelli, also a co-author of the analysis and current dean of the Harvard T.H. Chan School of Public Health, was paid at least $150,000 to provide testimony (together with other experts) for a group of parents and guardians of c...”Accessed: 2026-02-23
civil_lawsuitfederal_court
Added: 2026-02-23
· Updated: 2026-02-23
Embed this entity ·
<iframe src="https://epsteinindex.us.com/embed/document-tylenol-class-action-lawsuit-2023" width="400" height="200"></iframe>